CA Patent

CA2986735A1 — Solid forms of a compound for modulating kinases

Assigned to Plexxikon Inc · Expires 2016-12-01 · 9y expired

What this patent protects

Solid forms of Compound I (and its S-enantiomer, Compound II), active on protein kinases, were prepared and characterized: Compound I Also provided are methods of using the solid forms.

USPTO Abstract

Solid forms of Compound I (and its S-enantiomer, Compound II), active on protein kinases, were prepared and characterized: Compound I Also provided are methods of using the solid forms.

Drugs covered by this patent

Patent Metadata

Patent number
CA2986735A1
Jurisdiction
CA
Classification
—
Expires
2016-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Plexxikon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.